Vertex Pharmaceuticals (VRTX) is back in focus after Wolfe Research upgraded the stock to Outperform, citing increased ...

Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...

In the past week, Wolfe Research upgraded Vertex Pharmaceuticals from “Peer Perform” to “Outperform,” citing growing ...

Vertex makes an all-cash purchase of the 61-63 Crosby Street building, marking another step in creating its Manhattan ...

The firm said its upgrade reflects increased revenue forecasts for Vertex’s renal programs and higher valuation multiples, lifting its price target to $572. Bernstein sees a high probability that ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

Anthropic, AWS, Google Cloud, and OpenAI join Thomson Reuters Labs in the Trust in AI Alliance to define shared principles ...

Google has upgraded its Veo 3.1 AI model on Tuesday with better video generation, improved prompt understanding, stronger ...

Trinasolar, a global leader in smart photovoltaic (PV) and energy storage solutions, is pleased to announce the appointment ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

Learn more about whether Adeia Inc. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...